CLINICAL_TRIALS
safety_alert
· 2013-04-22
Clinical Trial Update: Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures
Summary
Post-authorization safety study update assessing the safety of Vimpat (lacosamide) as add-on therapy in patients with partial-onset seizures.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UCB Pharma | Conditions: Epilepsies, Partial | Status: COMPLETED | Results posted: 2013-04-22